期刊文献+

Sjgren综合征相关性干眼发病机制的研究进展 被引量:4

Recent advances in pathogenesis research on Sjgren syndrome related dry eye
下载PDF
导出
摘要 Sjgren综合征(Sjgren syndrome,SS)是一种主要累及外分泌腺、慢性炎症性的自身免疫性疾病,发病初期主要表现为泪液和唾液分泌减少所致的眼干、口干综合征,但在发病的晚期,会出现多系统损害的症状和体征。SS发病机制复杂,其确切发病机制国内外报道较少。目前,随着动物模型和实验检查技术的不断更新,关于SS发病机制的研究取得了新的进展,为早期诊断SS提供了新的理论证据。本文从遗传学、病理生理学方面就SS的发病机制做一综述,以期对SS相关性干眼的诊断和治疗有更新的认识。 Sjogren syndrome (SS) is a chronic autoimmune disease that primarily affects the exocrinosity glands. In the earlier stage of the disease, SS is characterized by the dry eye, dry mouth syndrome, because of the decrease of tear and saliva secretion. However, in the later stage of the disease, there are signs and symptom of multisystemic damage. The pathogenesis of SS is complicated, and there is no fmding of the exact pathogenesis of this disease at home and abroad. At present, with the continuous renew- al of animal models and technology of experiment and examination, the study about the pathogenesis of SS obtains new advance, and provides new theory evidences for the ear- lier diagnosis of SS. This article reviews the pathogenesis of SS to more understand the diagnosis and treatment of SS related drv eve.
出处 《眼科新进展》 CAS 北大核心 2013年第3期286-289,共4页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号:81100646) 天津市科委自然科学基金资助(编号:11JCYBJC26000)~~
关键词 SJOGREN综合征 干眼 发病机制 Sjogren Syndrome dry eye pathogenesis
  • 相关文献

参考文献36

  • 1Ramos-Casals M,Trejo O, Garcia-Carrasco M, Cervera R, De La Red G, Gil V, et al. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma [ J ]. J Rheumatol,2004,31 ( 3 ) :495-499.
  • 2Nguyen CQ, Cha SR, Peck AB. Sjogren' s syndrome ( SjS ) -like disease of mice: the importance of B lymphocytes and autoanti- bodies[J]. Front Biosci ,2007,12 ( 13 ) : 1767-1789.
  • 3The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop ( 2007 )[J]. Ocul Surf,2007,5 ( 2 ) :75-92.
  • 4Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease [ J ]. Ocul Surf,2009,7 ( 1 ) : 11-27.
  • 5Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexan- der EL, Carsons SE, et al. Classification criteria for Sjogren' s syndrome:a revised version of the European criteria proposed by the American-European Consensus Group [ J ]. Ann Rheum Dis,2002,61 (6) :554-558.
  • 6罗慧臣,李萍,肖卫国.M3R与AQP5在干燥综合征患者唇腺中的表达与意义[J].中国免疫学杂志,2011,27(1):79-81. 被引量:16
  • 7Cha S, Singson E, Cornelius J, Yagna JP, Knot H J, Peck AB, et al. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren' s syndrome-associated autoanti- bodies [ J ]. Rheumatol,2005,33 ( 2 ) : 296-306.
  • 8Smith A J, Jackson MW, Wang F, Cavill D, Rischmueller M, Gor- don TP. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulim in Sjogren syndrome [J]. Hum Im- munol,2005 ,55 ( 4 ) :411-415.
  • 9Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, et al. Anti-Ro ( SS-A ) and anti-La ( SS-B ) in patients with Sjogren' s syndrome [ J ]. Arthritis Rheum, 1986,29 ( 2 ) : 196- 206.
  • 10Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjogren' s syndrome, HLA class II is associated exclusively with autoantibody production and sprea- ding of the autoimmune response[J]. Arthritis Rheum ,2003,48 ( 8 ) : 2240-2245.

二级参考文献45

共引文献63

同被引文献32

  • 1朱萍,刘瑄,王艳玲.SmartPLUG泪点塞栓治疗泪液缺乏型干眼初步疗效[J].中国实用眼科杂志,2005,23(8):844-845. 被引量:12
  • 2陈丹,肖以钦.Smart PLUG泪点栓塞治疗水液缺乏型干眼疗效分析[J].中国实用眼科杂志,2006,24(12):1304-1305. 被引量:1
  • 3Subcommittee of the International Dry Eye workshop (2007). The definition and classification of dry eye disease : report of the definition and classification subcommittee of the International Dry Eye WorkShop[J]. Ocul Surf,2007,5(2) :75-92.
  • 4Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American college of rheumatology classification criteria for SjSgrcn' s syndrome : a data-driven, expert con- sensus approach in the Sjogren' s international collaborative clinical alliance cohort[J]. Arthritis Care Res (Hoboken) ,2012, 64(4) :475-487.
  • 5Pavesio CE, Deeory HH. Treatment of ocular inflammatory con- ditions with loteprednol etabonate [J]. Br J Ophthalmol, 2008, 92(4) :455-459.
  • 6Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland E J, De Paiva CS, et al. A randomized, double-masked, placebo-controlled, multieenter comparison of loteprednol etabonate ophthalmic suspension ,0.5% , and placebo for treatment of kerato- conjunctivitis sicca in patients with delayed tear clearance [J]. Am J Ophthalmol,2004,138 ( 3 ) :444-457.
  • 7Sheppard JD, Scoper SV, Samudre S. Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease[J]. J Ocul Pharmacol Ther,2011,27 (1) :23-27.
  • 8Ye Z,Honda S,Abe Y,et al. Influence of Work Duration or Physical Symptoms on Mental Health among Japanese Visual Display Terminal Users [J]. Ind Health,2007,45 ( 2 ) : 328-333.
  • 9邓小文,扶世杰.熏洗治疗的研究进展[J].医学信息,2015,(5):351-352.
  • 10Dry Eye World Study Group.The definition and classification of dry eye disease: report of definition and classification subcom- mittee of the international dry eye workshop(2007)[J]. Ocul Surf,2007,5(2) :75-92.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部